Aceragen Inc. (ACGN) Stock
ACGN is no longer traded. Aceragen was delisted from the Nasdaq in August 2023.
Prices on this page are historical; the last trade was August 21, 2023 at $0.38.
Aceragen stock price history
ACGN final trading statistics
- Final close
- $0.38
- Final trading day
- Aug 21, 2023
- Market cap at delisting
- —
- Shares outstanding
- —
- Final 52-week range
- $0.21 – $16.00
- Avg. volume (final 3 mo.)
- 92,463
- All-time high (split-adj.)
- $74119.86 · Jan 1996
- All-time low (split-adj.)
- $0.38 · Aug 2023
- Return since IPO
- -100.0%
- Beta
- —
- Book value / share
- —
- Price / book
- —
Aceragen annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $4.86M | -$23.4M | -$3.38 |
| FY2021 | $0.00 | $98.1M | $39.78 |
| FY2020 | $0.00 | -$112.7M | -$65.45 |
| FY2019 | $1.45M | -$56.5M | -$49.98 |
| FY2018 | $662.0K | -$59.9M | -$38.59 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Aceragen Inc.
Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and rheumatic diseases in the United States. Its clinical development pipeline includes ACG-701, which is in Phase 2 clinical trial for cystic fibrosis pulmonary exacerbations, as well as for melioidosis; and ACG-801 for farber disease. Aceragen, Inc. has a collaboration and option agreement with Scriptr Global, Inc. to identify, research, and develop gene therapy candidates for the treatment, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia. The company was formerly known as Idera Pharmaceuticals, Inc. and changed its name to Aceragen, Inc. in January 2023. Aceragen, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
Aceragen stock FAQ
What happened to Aceragen stock?
Aceragen stock was delisted from the Nasdaq. Its final close was $0.38 on August 21, 2023.
Is ACGN stock still trading?
No. ACGN was delisted from the Nasdaq in August 2023 and no longer trades on a U.S. exchange.
What was the last price of ACGN stock?
ACGN closed at $0.38 on its final trading day, August 21, 2023.
What were Aceragen's revenue and earnings in its last full fiscal year?
Aceragen reported revenue of $4.86M and net income of -$23.4M in fiscal 2022, its last full year as a public company.
When did Aceragen go public?
Aceragen Inc. stock began trading on January 25, 1996.